申请人:AUSONIA FARMACEUTICI S.r.l.
公开号:EP0164040A2
公开(公告)日:1985-12-11
Compounds of formula (I):
wherein:
A represents a CH-N02 group or a N-Cn group;
B represents CH2, O, S or a direct bond;
R represents a bicyclic or polycyclic residue, variously substituted and functionalized;
R1 and R2, which may be the same or different, are hydrogen or C1-C4 alkyl groups; and
n and m, which may be the same or different, are O,1, 2, 3 or 4;
are valuable pharmacological agents.
式(I)化合物:
其中
A 代表 CH-N02 基团或 N-Cn 基团;
B 代表 CH2、O、S 或直接键
R 代表经不同取代和官能化的双环或多环残基;
R1 和 R2(可以相同或不同)是氢或 C1-C4 烷基;以及
n 和 m(可以相同或不同)为 O、1、2、3 或 4;
是有价值的药剂。